1 Proqr Therapeutics N V Receivables Turnover Ratio (PRQR), from the fourth quarter 2025 to the fourth quarter 2024 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Competitors, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Proqr Therapeutics N v (NASDAQ: PRQR)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Proqr Therapeutics N V Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2024

Quarterly Results, Trends, Rankings, Statistics

According to Proqr Therapeutics N V Balance Sheet, in the fourth quarter 2025, company has not reported any Accounts receivable.
See Proqr Therapeutics N V Balance Sheet

If we take a look into Healthcare sector 472 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 3277.

What is Receivable Turnover Ratio?
What is Proqr Therapeutics N V Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PRQR Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-15.86 %	-20.24 %	-36.27 %	-1.53 %	-
Receivable Turnover Ratio (TTM)	-	-	-	-	-
PRQR's Total Ranking	# 3277	# 0	#	#	#
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	428.98 %	-22.15 %	-9.06 %	-77.53 %	401.48 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 162
Healthcare Sector	# 473
Overall Market	# 3277

Receivable Turnover Ratio Statistics
High	Average	Low
0.14	0.13	0.11
(Dec 31 2025)		(Dec 31 2024)

PRQR Company Profile • Back to PRQR Efficiency Comparisons • Compare PRQR Receivables Turnover Ratio to its Competitors

Financial Statements
Proqr Therapeutics N V 's Accounts Receivable	$ 0 Millions	Visit PRQR's Balance sheet
Proqr Therapeutics N V 's Sales TTM	$ 30 Millions	Visit PRQR's Income Statement
Sources of PRQR's Revenues		Visit PRQR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PRQR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PRQR's Growth Rates	PRQR's Roa	PRQR's Inventory Turnover Ratio	PRQR's Dividend Comparisons
PRQR's Profitability Ratios	PRQR's Roi	PRQR's Asset Turnover Ratio	PRQR's Dividend Growth
PRQR's Valuation Ratios	PRQR's Roe	PRQR's Financial Strength Ratios	PRQR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Dec 31 2025

Receivable at quarter ending Dec 31 2025

Date modified: 2026-07-07T12:40:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.